Jeroen Schouten

18PUBLICATIONS
106CO-AUTHORS
Epidemiological modellingPharmacogenomicsMedical infection agents (incl. prions)ChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 14, 2025
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients.

My-Luong Vuong, Omar Elkayal, Ruth Van Daele

|Jun 22, 2025
Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients.

Jaap W A Mouton, Julian D Machiels, Arthur M A Pistorius

|Mar 11, 2025
Pharmacokinetics and Target Attainment of Teicoplanin: A Systematic Review.

Jaap W A Mouton, Arnaud De Clercq, Peter De Paepe

|Mar 27, 2024
When to Stop Antibiotics in the Critically Ill?

Nathan D Nielsen, James T Dean, Elizabeth A Shald

|Oct 11, 2023
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies.

Anouk M E Jansen, Beatrijs Mertens, Isabel Spriet

|Aug 06, 2021
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.

Emma J Kooistra, Miranda van Berkel, Noortje F van Kempen

Pageof 3

Frequent Collaborators

7 joint publications

Roger J M Brüggemann

6 joint publications

Joost Wauters

5 joint publications

Jan J De Waele

5 joint publications

Paul E Verweij